Skip to the content
Search
Beyond Type 2
Menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
En Español
Search
Invisible:
ADA_News20
News From DiabetesMine™ D-Data Exchange 2020
The Beyond Type 2 team is spending a day at The DiabetesMine™ D-Data ExChange – this is our report from this enlightening event.
Diabetes Prevention Program Shows Persistent Reduction of Type 2 Diabetes Development
A 22-year follow up on the Diabetes Prevention Program Outcomes Study (DPPOS) indicates a continued significant reduction in the participants’ risk of developing Type 2 diabetes. Individuals in the...
Disparities in Diabetes and Diabetes Care—What Can We Do About It?
At this ADA 2020 session, systemic racism and implicit bias were clear contributors to poor health and healthcare outcomes for Black and Latinx communities.
Who Has Access to New Oral Diabetes Medications?
Racial and ethnic minorities may have a greater need for newer diabetes medications but functionally have less access.
FreeStyle Libre 2 Approved for Use in U.S.
The FreeStyle Libre 2 is a 14 day CGM system that transmits data every minute and now includes customizable high and low alerts without the need to scan the device. The Abbott announcement says it wil...
Lifestyle Interventions for Type 2 Diabetes Remission
Type 2 diabetes remission is a hot topic within the T2D community. At the American Diabetes Association's 80th Scientific Sessions, researchers presented data on the impact lifestyle intervention...
Dapagliflozin May Reduce the Onset of Type 2 Diabetes
Research presented at the American Diabetes Association's 80th Scientific Sessions revealed that the SGLT-2 Inhibitor, dapagliflozin, may reduce the onset of Type 2 diabetes when used in patients...
Nationwide Study in France Shows Dramatic Drop in DKA in Type 1 and Type 2 after Starting on FreeStyle Libre
The study included more that 70,000 patients living with diabetes and DKA rates were reduced by 52% for patients with T1D and 47% for patients with T2D.
Closed Loop Updates: Omnipod Horizon and Medtronic 780G data presented at ADA 2020
Data from four new clinical trials involving Hybrid Closed Loop systems, Medtronic 780G and Omnipod 5 Powered by Horizon was presented at ADA 2020.
